Novel and successful treatment of generalized arterial calcification of infancy in a patient with previously undescribed mutation in ENPP1

Angela J. Weingarten, Aaron Muller, Craig Langman, Abraham Groner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Newborn infants with generalized arterial calcification of infancy are at a substantial risk of sudden cardiac death. Treatment with bisphosphonates while helpful does not guarantee a favorable outcome. Herein we report a case of generalized arterial calcification of infancy from fetal diagnosis through childhood. The patient exhibited a previously unreported variant in the ENPP1 gene. Newborn echocardiogram and CT imaging showed extensive calcifications throughout the coronary arteries and aortic arch. Treatment started immediately after birth. Long-term follow-up has demonstrated disease regression. Early recognition and treatment were instrumental in reversing this infant's disease. Successful treatment included the previously reported use of pamidronate but with the novel inclusion of acetazolamide and Similac PM 60/40® (low calcium, low phosphate infant formula).

Original languageEnglish (US)
Article number101466
JournalProgress in Pediatric cardiology
DOIs
StateAccepted/In press - 2021

Keywords

  • Acetazolamide
  • Bisphosphonates
  • ENPP1
  • Generalized arterial calcification of infancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Novel and successful treatment of generalized arterial calcification of infancy in a patient with previously undescribed mutation in ENPP1'. Together they form a unique fingerprint.

Cite this